HomeAI · summaries
Storia in 2 fonti
Novo Nordisk inflammation-targeting drug misses mark in heart disease study
A Novo Nordisk drug missed the mark in a heart disease study, raising questions about targeting inflammation to prevent cardiovascular complications.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Novo Nordisk inflammation-targeting drug misses mark in heart disease study
A Novo Nordisk drug missed the mark in a heart disease study, raising questions about targeting inflammation to prevent cardiovascular complications.
- ·
endpoints.news
Novo Nordisk rocked by late-stage cardiovascular drug failure
An anti-inflammatory drug from Novo Nordisk unexpectedly failed in a Phase 3 study that aimed to prove a link between cardiovascular inflammation and heart disease.